Featured Jobs
|
Independent Retirement
|
|
Daybright Financial
|
|
EPIC RPS
|
|
Regional Sales Director-Mid Atlantic July Business Services
|
|
Director of Regulatory Operations and Compliance PCS Retirement
|
|
Spectrum Pension Consultants (part of Daybright Financial)
|
|
EPIC RPS
|
|
Director, Strategic Accounts and Channel Development July Business Services
|
|
Daybright Financial
|
|
Regional Sales Director-Heartland July Business Services
|
|
Nova 401(k) Associates
|
|
Internal Channel Sales Team Lead July Business Services
|
|
Stones River Consulting
|
|
Experienced Employee Benefits Attorney Shipman & Goodwin LLP
|
|
Relationship Manager – Defined Contributions Daybright Financial
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Eli Lilly Strikes Back Against Pharmacy Compounders and Telehealth Platforms
Holland & Knight 
June 13, 2025 "Telehealth companies selling compounded drugs are making modest inroads into the market for popular weight loss drugs that big pharma spent decades and billions of dollars to develop and bring to market. The compounded products, with fewer barriers to entry, are reaching a broader consumer market than U.S. Food and Drug Administration (FDA)-approved glucagon-like peptide-1 (GLP-1) products, and at least one brand pharma player -- Eli Lilly and Company (Lilly) -- is turning the courts to reverse the trend." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |